| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.57B | 2.39B | 1.91B | 1.81B | 2.27B | 1.53B |
| Gross Profit | 954.86M | 919.92M | 737.05M | 696.64M | 861.32M | 554.26M |
| EBITDA | 657.29M | 597.59M | 427.63M | 435.03M | 661.40M | 423.38M |
| Net Income | 426.54M | 399.71M | 280.30M | 254.22M | 437.75M | 312.77M |
Balance Sheet | ||||||
| Total Assets | 3.79B | 3.82B | 3.17B | 2.97B | 2.89B | 2.43B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 1.14B | 728.80M | 720.69M | 833.70M | 846.85M |
| Total Debt | 432.90M | 438.19M | 415.41M | 374.87M | 197.63M | 175.33M |
| Total Liabilities | 1.55B | 1.64B | 1.33B | 1.36B | 1.44B | 1.04B |
| Stockholders Equity | 2.25B | 2.17B | 1.84B | 1.61B | 1.44B | 1.38B |
Cash Flow | ||||||
| Free Cash Flow | 783.56M | 808.91M | 261.73M | 85.54M | 727.92M | 565.69M |
| Operating Cash Flow | 817.31M | 848.61M | 328.46M | 136.27M | 736.60M | 579.84M |
| Investing Cash Flow | -198.38M | -265.06M | -70.41M | -3.00M | -273.91M | -99.75M |
| Financing Cash Flow | -397.21M | -329.07M | -250.59M | -240.46M | -459.06M | -26.82M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $5.98B | 24.96 | 51.98% | 3.69% | 51.19% | 456.59% | |
76 Outperform | $14.27B | 29.43 | 31.39% | 0.95% | 27.00% | 63.47% | |
75 Outperform | $13.24B | 22.99 | 11.73% | 1.43% | 7.54% | 2.73% | |
70 Outperform | $12.76B | 29.35 | 20.29% | 1.33% | 20.99% | 25.02% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $6.51B | 27.20 | 19.30% | 1.63% | 12.77% | 36.43% | |
63 Neutral | $12.59B | 22.00 | 6.36% | 2.52% | -5.41% | 25.28% |
On December 30, 2025, Houlihan Lokey, Inc. entered into an amended and restated voting trust agreement that replaces its prior 2015 voting trust structure governing Class B common stock. The revised agreement updates termination triggers, including ending the trust 10 years after the date on which all Class B shares convert into Class A or once the trust’s holdings fall below 5% of outstanding common stock, and introduces a requirement that any trust-held stake above 30% of the company’s outstanding shares after that conversion be voted proportionally with other shareholders. It also broadens employee flexibility by allowing former employees (no longer employed for at least 12 months) to have their shares released from the trust after the final conversion date and by expanding circumstances under which employees can withdraw shares for certain pledging, hedging, monetization, or similar transactions, subject to the company’s insider trading policy. Because some directors serve as trustees and hold Class B shares subject to the trust, a special committee of disinterested directors was formed to review and negotiate the new agreement, and, after consulting independent advisors and management, the committee unanimously approved the amended and restated voting trust agreement and authorized officers to execute it, clarifying governance and voting mechanics for major shareholders and employees.
The most recent analyst rating on (HLI) stock is a Buy with a $228.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.
On September 30, 2025, Houlihan Lokey‘s Board of Directors approved an increase in the board size from ten to eleven members, appointing R. Scott Mund as an independent Class II director effective October 1, 2025. Mr. Mund, a partner at Deloitte LLP with extensive experience in advising multinational companies on M&A and corporate governance, will serve until the 2026 Annual Meeting of Stockholders. His appointment to the Nominating and Corporate Governance Committee is expected to enhance the company’s strategic planning and governance capabilities. Mr. Mund will receive standard compensation, including an award of restricted shares valued at $100,000, vesting over three years.
The most recent analyst rating on (HLI) stock is a Buy with a $230.00 price target. To see the full list of analyst forecasts on Houlihan Lokey stock, see the HLI Stock Forecast page.